Related references
Note: Only part of the references are listed.Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution
C. Colin et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2013)
Search for Distinctive Markers in DNT and Cortical Grade II Glioma in Children: Same Clinicopathological and Molecular Entities?
Laetitia Padovani et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
BRAF Alterations in Primary Glial and Glioneuronal Neoplasms of the Central Nervous System With Identification of 2 Novel KIAA1549:BRAF Fusion Variants
Alex Lin et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Diffuse form of dysembryoplastic neuroepithelial tumour: the histological and immunohistochemical features of a distinct entity showing transition to dysembryoplastic neuroepithelial tumour and ganglioglioma
I. Bodi et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2012)
Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody
David Capper et al.
ACTA NEUROPATHOLOGICA (2011)
Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma
Genevieve Schindler et al.
ACTA NEUROPATHOLOGICA (2011)
BRAF-KIAA1549 Fusion Predicts Better Clinical Outcome in Pediatric Low-Grade Astrocytoma
Cynthia Hawkins et al.
CLINICAL CANCER RESEARCH (2011)
CD34 and microtubule-associated protein 2 expression in dysembryoplastic neuroepithelial tumours with an emphasis on dual expression in non-specific types
Chang Ohk Sung et al.
HISTOPATHOLOGY (2011)
BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic Implications
Dora Dias-Santagata et al.
PLOS ONE (2011)
Integrated Molecular Genetic Profiling of Pediatric High-Grade Gliomas Reveals Key Differences With the Adult Disease
Barbara S. Paugh et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas
Margaret J. Dougherty et al.
NEURO-ONCOLOGY (2010)
Pilocytic astrocytoma of the optic pathway: a tumour deriving from radial glia cells with a specific gene signature
Aurelie Tchoghandjian et al.
BRAIN (2009)
Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas
Tim Forshew et al.
JOURNAL OF PATHOLOGY (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma
D. T. W. Jones et al.
ONCOGENE (2009)
Analysis of the IDH1 codon 132 mutation in brain tumors
Joerg Balss et al.
ACTA NEUROPATHOLOGICA (2008)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
High-resolution DNA melting analysis for simple and efficient molecular diagnostics
Gudrun H. Reed et al.
PHARMACOGENOMICS (2007)
Expression of CD34 as a novel marker for glioneuronal lesions associated with chronic intractable epilepsy
P. Deb et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2006)
Pediatric oligodendrogliomas: A study of molecular alterations on 1p and 19q using fluorescence in situ hybridization
R Raghavan et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)